gliclazide has been researched along with Periodontitis in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Periodontitis: Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, AA | 1 |
| Morais, HB | 1 |
| Medeiros, CACX | 1 |
| Brito, GAC | 1 |
| Guedes, PMM | 1 |
| Hiyari, S | 1 |
| Pirih, FQ | 1 |
| Araújo Júnior, RF | 1 |
1 other study available for gliclazide and Periodontitis
| Article | Year |
|---|---|
Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model.
Topics: Alveolar Bone Loss; Animals; Antioxidants; Cathepsin K; Fluorescent Antibody Technique; Gingiva; Gli | 2019 |